A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic Shock

New England Journal of Medicine

Volumn 317, Issue 11, 1987, Pages 653-658

  Bone, Roger C ^a   Fisher, Charles J ^b   Clemmer, Terry P ^b   Slotman, Gus J ^b   Metz, Craig A ^b   Balk, Robert A ^b  

^a Methylprednisolone Severe Sepsis Study Group ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE;

ADULT; AGED; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIOLOGY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NONHUMAN; SEPSIS; SEPTIC SHOCK; THERAPY;

EID: 0023252009     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198709103171101     Document Type: Article

References (31)

1. Parker MM, Parrillo JE. Septic shock: hemodynamics and pathogenesis. JAMA 1983; 250: 3324–7.
2. Shubin H, Weil MH. Bacterial shock. JAMA 1976; 235: 421–4.
3. Kreger BE, Craven DE, Carling PC, McCabe WR. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med 1980; 63: 332–43.
4. Kreger BE, Craven DE, McCabe WR. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980; 68: 344–55.
5. MacLean LD, Mulligan WG, McLean APH, Duff JH. Patterns of septic shock in man: a detailed study of 56 patients. Ann Surg 1967; 166: 543–62.
6. Pollack MM, Fields AI, Ruttimann UE. Distributions of cardiopulmonary variables in pediatric survivors and nonsurvivors of septic shock. Crit Care Med 1985; 13: 454–9.
7. Abraham E, Shoemaker WC, Bland RD, Cobo JC. Sequential cardiorespiratory patterns in septic shock. Crit Care Med 1983; 11: 799–803.
8. Abraham E, Bland RD, Cobo JC, Shoemaker WC. Sequential cardiorespiratory patterns associated with outcome in septic shock. Chest 1984; 85: 75–80.
9. Kaplan RL, Sahn SA, Petty TL. Incidence and outcome of the respiratory distress syndrome in gram-negative sepsis. Arch Intern Med 1979; 139: 867–9.
10. Fein AM, Lippmann M, Holtzman H, Eliraz A, Goldberg SK. The risk factors, incidence, and prognosis of ARDS following septicemia. Chest 1983; 83: 40–2.
11. Nicholson DP. Glucocorticoids in the treatment of shock and the adult respiratory distress syndrome. Clin Chest Med 1982; 3: 121–32.
12. Nicholson. Corticosteroids in the treatment of septic shock and the adult respiratory distress syndrome. Med Clin North Am 1983; 67: 717–24.
13. Blaisdell FW. Controversy in shock research; con: the role of steroids in septic shock. Circ Shock 1981; 8: 673–82.
14. Schumer W. Controversy in shock research; pro: the role of steroids in septic shock. Circ Shock 1981; 8: 667–71.
15. Kass EH. High-dose corticosteroids for septic shock. N Engl J Med 1984; 311: 1178–9.
16. Karakusis PH. Considerations in the therapy of septic shock. Med Clin North Am 1986; 70: 933–44.
17. Hinshaw LB, Beller-Todd BK, Archer LT, et al. Review update: current management of the septic shock patient: experimental basis for treatment. Circ Shock 1982; 9: 543–53.
18. Ottosson J, Brandberg Å, Erikson B, Hedman L, Davidson I, Söderberg R. Experimental septic shock: effects of corticosteroids. Circ Shock 1982; 9: 571–7.
19. Brigham KL, Bowers RE, McKeen CR. Methylprednisolone prevention of increased lung vascular permeability following endotoxemia in sheep. J Clin Invest 1981; 67: 1103–10.
20. Hinshaw LB, Archer LT, Beller-Todd BK, Benjamin B, Flournoy DJ, Passey R. Survival of primates in lethal septic shock following delayed treatment with steroid. Circ Shock 1981; 8: 291–300.
21. Demling RH, Smith M, Gunther R, Wandzilq KT. Endotoxin-induced lung injury in unanesthetized sheep: effect of methylprednisolone. Circ Shock 1981; 8: 351–60.
22. Elinger JH, Seyde WC, Longnecker DE. Methylprednisolone plus ibuprofen increases mortality in septic rats. Circ Shock 1984; 14: 203–8.
23. Hinshaw LB, Beller BK, Archer LT, Flournoy DJ, White GL, Phillips RW. Recovery from lethal Escherichia coli shock in dogs. Surg Gynecol Obstet 1979; 149: 545–53.
24. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg 1976; 184: 333–41.
25. Sheagren JN. Septic shock and corticosteroids. N Engl J Med 1981; 305: 456–8.
26. Sprung CL, Caralis PV, Marcial EH, et al. The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study. N Engl J Med 1984; 311: 1137–43.
27. Thompson WL, Gurley HT, Lutz BA, Jackson DL, Kvols LK, Morris IA. Inefficacy of glucocorticoids in shock (double-blind study). Clin Res 1976; 24: 258A. abstract.
28. Bell RC, Coalson JJ, Smith JD, Johanson WG Jr. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 1983; 99: 293–8.
29. Henao F, Aldrete JS. Multiple systems organ failure: Is it a specific entity? South Med J 1985; 78: 329–34.
30. Haynes RC Jr, Murad F. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of adrenocortical steroid biosynthesis. In: Gilman AG, Goodman LS, Gilman A, eds. The pharmacological basis of therapeutics. 6th ed. New York: Macmillan, 1980:1466–96.
31. Weigelt JA, Norcross JF, Borman KR, Snyder WH III. Early steroid therapy for respiratory failure. Arch Surg 1985; 120: 536–40.